FGFR3 and AL amyloidosis: FGFR3 mutations have also been identified in many other cancer types, including 3% of squamous cell lung carcinoma [23], cervical cancers [50], multiple myeloma [51], prostate cancer [52] and spermatocytic seminomas [53].